{
    "organizations": [],
    "uuid": "007ab30762db8e0ebdca580d81dde144f9a1f818",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-genomic-health-reports-q4-earnings/brief-genomic-health-reports-q4-earnings-per-share-0-05-idUSASB0C9G1",
    "ord_in_thread": 0,
    "title": "BRIEF-Genomic Health Reports Q4 Earnings Per Share $0.05",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 8 (Reuters) - Genomic Health Inc:\n* GENOMIC HEALTH ANNOUNCES 2017 FOURTH QUARTER AND YEAR-END FINANCIAL RESULTS, PROVIDES 2018 FINANCIAL OUTLOOK\n* SEES 2018 GAAP EPS OF $ 0.16 TO $ 0.22 * GENOMIC HEALTH - ‍WILL NO LONGER PROVIDE ONCOTYPE SEQ LIQUID SELECT TEST OR FURTHER INVEST IN NON-PROPRIETARY NGS-BASED PANELS​\n* SEES 2018 NON-GAAP EPS IN RANGE OF $ 0.32 TO $ 0.50\n* Q4 EARNINGS PER SHARE VIEW $0.07, REVENUE VIEW $88.9 MILLION — THOMSON REUTERS I/B/E/S\n* ‍WILL REDUCE POSITIONS BY ABOUT 10 PERCENT & TAKE A CHARGE OF ABOUT $10 MILLION IN Q1​\n* FY2018 EARNINGS PER SHARE VIEW $0.34, REVENUE VIEW $383.8 MILLION — THOMSON REUTERS I/B/E/S\n* GENOMIC HEALTH - IN 2018, PLANS TO DIRECT RESOURCES TO EXPAND ITS ONCOTYPE DX OFFERING\n* GENOMIC HEALTH - TO NO LONGER PROVIDE ONCOTYPE SEQ LIQUID SELECT TEST/FURTHER INVEST IN NON-PROPRIETARY NEXT-GENERATION SEQUENCING (NGS)-BASED PANELS\n* IN CONNECTION TO THE SHIFT IN FOCUS, CO WILL REDUCE POSITIONS BY ABOUT 10 PERCENT\n* GENOMIC HEALTH-TO TAKE CHARGE OF ABOUT $10 MILLION IN Q1 FOR COSTS WITH PERSONNEL REDUCTIONS&WRITE-OFF OF CERTAIN ASSETS ASSOCIATED WITH NGS-BASED PANELS Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-03-08T21:16:00.000+02:00",
    "crawled": "2018-03-09T14:17:01.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "genomic",
        "health",
        "inc",
        "genomic",
        "health",
        "announces",
        "fourth",
        "quarter",
        "financial",
        "result",
        "provides",
        "financial",
        "outlook",
        "see",
        "gaap",
        "eps",
        "genomic",
        "health",
        "longer",
        "provide",
        "oncotype",
        "seq",
        "liquid",
        "select",
        "test",
        "invest",
        "see",
        "eps",
        "range",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "reduce",
        "position",
        "percent",
        "take",
        "charge",
        "million",
        "fy2018",
        "earnings",
        "per",
        "share",
        "view",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "genomic",
        "health",
        "plan",
        "direct",
        "resource",
        "expand",
        "oncotype",
        "dx",
        "offering",
        "genomic",
        "health",
        "longer",
        "provide",
        "oncotype",
        "seq",
        "liquid",
        "select",
        "invest",
        "sequencing",
        "ng",
        "panel",
        "connection",
        "shift",
        "focus",
        "co",
        "reduce",
        "position",
        "percent",
        "genomic",
        "take",
        "charge",
        "million",
        "q1",
        "cost",
        "personnel",
        "reduction",
        "certain",
        "asset",
        "associated",
        "panel",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}